Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Benitec Biopharma Inc. BNTC

Full chart Compare
Set alert

Price alert · BNTC

All alert types
8.90 USD +0.50 (+5.95%)

Nov 4, 2026, 11:47 AM EST

8.67 Day range 9.13
7.89 52-week range 15.86
YTD
-33.93%
1 year
-43.35%

Financial health

Altman Z-Score

43.13 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -13.7×
FY 2017: -9.6×FY 2018: -6.6×FY 2019: 9.6×FY 2020: -1.9×FY 2021: -2.6×FY 2022: -1.0×FY 2023: -0.3×FY 2024: -2.7×FY 2025: -11.1×FY 2026: -13.7×
FY 2017 5y median -2.7× FY 2026
P/S 0.0×
FY 2017: 430×FY 2018: 25.7×FY 2019: 3.2×FY 2020: 333×FY 2021: 1238×FY 2022: 519×FY 2023: 75.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 3.5×
FY 2017: 3.9×FY 2018: 8.2×FY 2019: 3.3×FY 2020: 3.2×FY 2021: 3.6×FY 2022: 13.2×FY 2023: 27.9×FY 2024: 1.6×FY 2025: 4.4×FY 2026: 3.5×
FY 2017 5y median 4.4× FY 2026
P/FCF -37.5×
FY 2017: -10.0×FY 2018: -13.1×FY 2019: 12.6×FY 2020: -4.2×FY 2021: -5.6×FY 2022: -2.4×FY 2023: -0.3×FY 2024: -3.8×FY 2025: -17.9×FY 2026: -37.5×
FY 2017 5y median -3.8× FY 2026
EV/EBITDA -8.8×
FY 2017: -21.4×FY 2018: -5.9×FY 2019: 16.1×FY 2020: -2.9×FY 2021: -4.0×FY 2022: -1.9×FY 2023: -0.2×FY 2024: -1.1×FY 2025: -7.9×FY 2026: -8.8×
FY 2017 5y median -1.9× FY 2026
EV/Sales 0.0×
FY 2017: 341×FY 2018: 22.0×FY 2019: 1.9×FY 2020: 236×FY 2021: 906×FY 2022: 475×FY 2023: 49.4×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -2.7%
FY 2017: -10.0%FY 2018: -7.6%FY 2019: 7.9%FY 2020: -23.6%FY 2021: -17.9%FY 2022: -42.0%FY 2023: -320.2%FY 2024: -26.3%FY 2025: -5.6%FY 2026: -2.7%
FY 2017 5y median -26.3% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 18.3%FY 2018: 89.7%FY 2019: 91.1%FY 2020: 290.7%FY 2021: -108.5%FY 2022: 87.7%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: -8132.4%FY 2018: -198.4%FY 2019: 21.2%FY 2020: -8537.1%FY 2021: -23044.1%FY 2022: -24457.5%FY 2023: -25441.3%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: -2860.4%FY 2018: -280.1%FY 2019: 21.4%FY 2020: -8529.9%FY 2021: -23528.8%FY 2022: -24942.5%FY 2023: -26082.7%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -25.7%
FY 2017: -26.0%FY 2018: -89.5%FY 2019: 22.5%FY 2020: -80.8%FY 2021: -69.4%FY 2022: -631.8%FY 2023: -9684.2%FY 2024: -46.0%FY 2025: -39.0%FY 2026: -25.7%
FY 2017 5y median -46.0% FY 2026
ROIC -28.8%
FY 2017: 152.2%FY 2018: -23.5%FY 2019: 14.9%FY 2020: -76.7%FY 2021: -67.2%FY 2022: -483.5%FY 2023: -2507.4%FY 2024: -47.3%FY 2025: -42.6%FY 2026: -28.8%
FY 2017 5y median -47.3% FY 2026
ROA -24.9%
FY 2017: -24.6%FY 2018: -57.5%FY 2019: 13.6%FY 2020: -70.5%FY 2021: -64.9%FY 2022: -304.8%FY 2023: -438.2%FY 2024: -41.7%FY 2025: -38.1%FY 2026: -24.9%
FY 2017 5y median -41.7% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -24.2%FY 2018: 2146.5%FY 2019: 296.5%FY 2020: -99.4%FY 2021: -39.2%FY 2022: 23.7%FY 2023: 2.7%FY 2024: -100.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income -22.6%
FY 2017: 14.5%FY 2018: 45.2%FY 2019: 142.3%FY 2020: -324.1%FY 2021: -64.2%FY 2022: -31.3%FY 2023: -6.9%FY 2024: -17.9%FY 2025: -85.7%FY 2026: -22.6%
FY 2017 FY 2026
EPS (diluted) 6.7%
FY 2017: -49.5%FY 2018: -63.0%FY 2019: 127.5%FY 2020: -128.5%FY 2021: -236.7%FY 2022: 29.2%FY 2023: 26.9%FY 2024: 81.0%FY 2025: 60.8%FY 2026: 6.7%
FY 2017 FY 2026
Free Cash Flow 29.6%
FY 2017: 58.8%FY 2018: -2.1%FY 2019: 150.9%FY 2020: -273.9%FY 2021: -71.1%FY 2022: -21.9%FY 2023: -13.2%FY 2024: -8.7%FY 2025: -20.5%FY 2026: 29.6%
FY 2017 FY 2026

Financial Health

Current Ratio 34.0×
FY 2017: 25.7×FY 2018: 8.2×FY 2019: 10.2×FY 2020: 9.5×FY 2021: 15.1×FY 2022: 1.9×FY 2023: 0.9×FY 2024: 10.5×FY 2025: 54.7×FY 2026: 34.0×
FY 2017 5y median 10.5× FY 2026
Quick Ratio 34.0×
FY 2017: 25.8×FY 2018: 8.2×FY 2019: 10.2×FY 2020: 9.5×FY 2021: 15.1×FY 2022: 1.9×FY 2023: 0.9×FY 2024: 10.5×FY 2025: 54.7×FY 2026: 34.0×
FY 2017 5y median 10.5× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.3×FY 2023: 2.8×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 3.5×
FY 2017: 5.6×FY 2018: 1.0×FY 2019: -11.1×FY 2020: 1.2×FY 2021: 1.5×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 2.3×FY 2025: 2.3×FY 2026: 3.5×
FY 2017 5y median 2.3× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -2266×FY 2022: -558×FY 2023: -578×FY 2024: 0.0×FY 2025: 12.7×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: -1.4%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30